Italfarmaco Webinar: Givinostat Development Program Updates

- Posted in All News, Webinars

Dr. Paolo Bettica will review recently completed study analysis for the Italfarmaco Phase 3 randomized controlled trial of givinostat in boys with Duchenne muscular dystrophy (DMD). He will answer your questions about what the results mean and where Italfarmaco is going next with development of givinostat for DMD.

Watch Webinar Recording

Related Posts

Share This Page

Make an Impact

You can advance the care, treatment and cure for Duchenne muscular dystrophy. Contributions in any amount can truly make a difference and can be credited to a fundraiser or event from the list below.

Donate